NYSE ARCA | ETF
Under normal circumstances, the fund invests at least 80% of its net assets inU. S.-listed equity securities or ADRs of Treatments, Testing and Advancements Companies.
In general, the index seeks to be comprised of companies performing advancements in research, development, and commercialization of treatments or vaccines for infectious diseases, or engaged in the advancement of research, development, manufacturing, and provision of biological tests for patients.
The fund is non-diversified.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
AGPXX | Invesco Short-Term Investments Trust Government & Agency Portfolio Institutional | null | null | 99.72% |
ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 10.74% |
DGX | Quest Diagnostics Incorporated | Healthcare | Diagnostics & Research | 6.72% |
LH | Laboratory Corporation of America Holdings | Healthcare | Diagnostics & Research | 5.54% |
BNTX | BioNTech SE | Healthcare | Biotechnology | 5.29% |
BIO | Bio-Rad Laboratories Inc | Healthcare | Medical Devices | 4.75% |
PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 4.53% |
ZLAB | Zai Lab Ltd | Healthcare | Biotechnology | 4.27% |
BCRX | BioCryst Pharmaceuticals Inc | Healthcare | Biotechnology | 4.08% |
QL1A | QUIDELORTHO DL-001 | Healthcare | Medical Devices | 4.04% |
IMCR | Immunocore Holdings Ltd | Healthcare | Biotechnology | 3.42% |
DVAX | Dynavax Technologies Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 3.34% |
MRNA | Moderna Inc | Healthcare | Biotechnology | 3.05% |
ABCL | Abcellera Biologics Inc | Healthcare | Biotechnology | 2.99% |
OPK | Opko Health Inc | Healthcare | Diagnostics & Research | 2.66% |
NK | NantKwest Inc | Healthcare | Biotechnology | 2.64% |
NVAX | Novavax Inc | Healthcare | Biotechnology | 2.58% |
VIR | Vir Biotechnology Inc | Healthcare | Biotechnology | 2.56% |
ICVX | Icosavax Inc | Healthcare | Biotechnology | 1.66% |
TKM | Arbutus Biopharma Corp | Other | Other | 1.66% |